Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Hypha Labs (FUNI) EBT (2016 - 2025)

Historic EBT for Hypha Labs (FUNI) over the last 16 years, with Q3 2025 value amounting to -$558415.0.

  • Hypha Labs' EBT fell 1687.8% to -$558415.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 12636.79%. This contributed to the annual value of -$3.1 million for FY2025, which is 12868.7% down from last year.
  • Per Hypha Labs' latest filing, its EBT stood at -$558415.0 for Q3 2025, which was down 1687.8% from -$562023.0 recorded in Q2 2025.
  • Hypha Labs' EBT's 5-year high stood at $18201.0 during Q1 2021, with a 5-year trough of -$1.3 million in Q4 2024.
  • For the 5-year period, Hypha Labs' EBT averaged around -$359097.1, with its median value being -$277603.0 (2021).
  • In the last 5 years, Hypha Labs' EBT surged by 10288.84% in 2021 and then plummeted by 792879.66% in 2025.
  • Quarter analysis of 5 years shows Hypha Labs' EBT stood at -$277603.0 in 2021, then skyrocketed by 35.23% to -$179809.0 in 2022, then increased by 13.87% to -$154877.0 in 2023, then tumbled by 764.97% to -$1.3 million in 2024, then soared by 58.32% to -$558415.0 in 2025.
  • Its EBT was -$558415.0 in Q3 2025, compared to -$562023.0 in Q2 2025 and -$641822.0 in Q1 2025.